Wellgistics Health, Inc. (WGRX) intrinsic value & 10-year financials
Wellgistics Health, Inc. (WGRX) has a Graham intrinsic value of $33.19 per share. Over the last 4 fiscal years revenue shrank 17.7% a year to $23.3M, with an average return on invested capital of -201.5%.
- Graham intrinsic value
- $33.19
- Revenue (FY2025)
- $23.3M
- Revenue growth (4-yr CAGR)
- -17.7%
- ROIC (10-yr avg)
- -201.5%
- Free cash flow (FY2025)
- —
WGRX 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $23.3M | -$101.3M | -$1.43 | — | -401.7% | -667.4% |
| FY2024 | $18.1M | -$6.9M | -$0.15 | — | -33.9% | -50.5% |
| FY2023 | $34.5M | -$2.9M | -$0.06 | — | -8.4% | 113.5% |
| FY2022 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Wellgistics Health, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Wellgistics Health, Inc. has earned high returns on invested capital, averaging 18.8% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Wellgistics Health, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Wellgistics Health, Inc. is modeled at -17.7% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $33.19 per share.